396064000: Fluticasone propionate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\...

\Glucocorticoid (substance)\Fluticasone propionate

\Fluorinated corticosteroid\Fluticasone propionate

\Drug or medicament (substance)\Corticosteroid and/or corticosteroid derivative\Glucocorticoid (substance)\Fluticasone propionate
\Drug or medicament (substance)\Corticosteroid and/or corticosteroid derivative\Fluorinated corticosteroid\Fluticasone propionate
\Drug or medicament (substance)\Hormone\Steroid hormone\Glucocorticoid (substance)\Fluticasone propionate
\Drug or medicament (substance)\Hormone\Steroid hormone\Fluorinated corticosteroid\Fluticasone propionate

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Organic cyclic compound\Polycyclic compound\Steroid (substance)\...

\Corticosteroid and/or corticosteroid derivative\Glucocorticoid (substance)\Fluticasone propionate
\Corticosteroid and/or corticosteroid derivative\Fluorinated corticosteroid\Fluticasone propionate

\Androstane\Fluticasone propionate

\Steroid hormone\Glucocorticoid (substance)\Fluticasone propionate
\Steroid hormone\Fluorinated corticosteroid\Fluticasone propionate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Fluticasone propionate	Is a	Anti-inflammatory agent	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Is a	Fluticasone (substance)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Is modification of (attribute)	Fluticasone (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Is a	corticostéroïde pour administration pulmonaire	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Has disposition	Androgen receptor agonist (disposition)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Has disposition	Gonadal hormone	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Is a	Androstane	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Is a	Fluorinated corticosteroid	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Is a	Glucocorticoid (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate	Has disposition	Hormone (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Fluticasone propionate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate topical preparation (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate [respiratory use]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms/blister disks+disk inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 100micrograms/blister disks+disk inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms/blister disks+disk inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms/blister disks refill (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 100micrograms/blister disks refill	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms/blister disks refill	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 25micrograms inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 125micrograms inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 500micrograms/blister disks+disk inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 500micrograms/blister disks refill (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms breath-actuated dry powder inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 100micrograms breath-actuated dry powder inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms breath-actuated dry powder inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 500micrograms breath-actuated dry powder inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 0.5mg/2mL nebulization unit	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 2mg/2mL nebulization unit	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 125micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 250micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms CFC-free inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 50micrograms aqueous nasal spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 400micrograms single-use nasal drops (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate[skin]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 0.05% cream (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 50 microgram/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 44mcg/actn aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg/actn aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 220mcg/actn aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 0.05% spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 9g spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 44mcg aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg/spray aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 110mcg aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 220mcg aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 220mcg/spray aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 44mcg/inh aerosol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 50mcg/spray spray	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 125mcg/spr inhalant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 250mcg/spr inhalant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 50mcg/spr inhalant	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 100mcg/50mcg powder for oral inhalation (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Respiratory fluticasone	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing fluticasone in nasal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone [nose]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone- and salmeterol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 250mcg/50mcg powder for oral inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate + salmeterol xinafoate 500mcg/50mcg powder for oral inhalation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler (substance)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone- and salmeterol-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/250micrograms inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/125micrograms inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Salmeterol+fluticasone propionate 25micrograms/50micrograms inhaler	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)
Fluticasone propionate 0.05% cream (substance)	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 0.05% cream (substance)	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 50 microgram/g cutaneous ointment	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 50 microgram/g cutaneous ointment	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 50 microgram/actuation nasal spray	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 50 microgram/actuation nasal spray	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 125 microgram/actuation pressurised suspension for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 125 microgram/actuation pressurised suspension for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 250 microgram/actuation powder for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 250 microgram/actuation powder for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 100 microgram/actuation powder for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 100 microgram/actuation powder for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 250 microgram/actuation pressurised suspension for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 250 microgram/actuation pressurised suspension for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 25 microgram/actuation pressurised suspension for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 25 microgram/actuation pressurised suspension for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 500 microgram/actuation powder for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 500 microgram/actuation powder for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 50 microgram/actuation powder for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 50 microgram/actuation powder for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 50 microgram/actuation pressurised suspension for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 50 microgram/actuation pressurised suspension for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	Has precise active ingredient	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	Has basis of strength substance (attribute)	False	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation	Has precise active ingredient	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/1 actuation conventional release pressurized suspension for inhalation (clinical drug)	Has basis of strength substance (attribute)	True	Fluticasone propionate	Inferred relationship	Existential restriction modifier (core metadata concept)	2

Page 1 of 2 End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1470004013	Fluticasone propionate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489689017	Fluticasone propionate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1470004013	Fluticasone propionate (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1470004013	Fluticasone propionate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1489689017	Fluticasone propionate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
1489689017	Fluticasone propionate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
11431000188116	fluticasone propionate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
812961000172111	propionate de fluticasone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
11431000188116	fluticasone propionate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
812961000172111	propionate de fluticasone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module